Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis A Gimotty

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Cancer Research|March 18, 2004
Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cellsJose R Conejo-Garcia, Fabian Benencia, Maria C Courreges, et al.
Journal of the American Academy of Dermatology|March 9, 2018
The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sexAndrew J Sinnamon, Cimarron E Sharon, Yun Song, et al.
Plos One|April 7, 2016
A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid LeukemiaCaroline E Sloan, Marlise R Luskin, Anne M Boccuti, et al.
Cell Reports|August 1, 2023
The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR<sup>+</sup> CD8<sup>+</sup> effector state, and its deletion improves checkpoint blockadeSusan E McClory, Oishi Bardhan, Kelly S Rome, et al.
Molecular Cancer Therapeutics|August 14, 2013
EGFR inhibition promotes an aggressive invasion pattern mediated by mesenchymal-like tumor cells within squamous cell carcinomasDevraj Basu, Arnaud F Bewley, Steven M Sperry, et al.
Journal of Translational Medicine|December 17, 2009
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18Ioannis Alagkiozidis, Andrea Facciabene, Carmine Carpenito, et al.
Cancer Immunology, Immunotherapy : CII|October 25, 2011
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remissionChristina S Chu, Jean Boyer, Daniel S Schullery, et al.
Annals of Surgical Oncology|July 29, 2015
Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node PositivityEdmund K Bartlett, Madalyn G Peters, Anne Blair, et al.
Cancer Research|January 7, 2006
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinomaDavid A Tuveson, Liqin Zhu, Aarthi Gopinathan, et al.
Cancer Research|April 19, 2007
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage displayRolf K Swoboda, Rajasekharan Somasundaram, Laura Caputo, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Cancer Research|March 18, 2004
Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cellsJose R Conejo-Garcia, Fabian Benencia, Maria C Courreges, et al.
Journal of the American Academy of Dermatology|March 9, 2018
The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sexAndrew J Sinnamon, Cimarron E Sharon, Yun Song, et al.
Plos One|April 7, 2016
A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid LeukemiaCaroline E Sloan, Marlise R Luskin, Anne M Boccuti, et al.
Cell Reports|August 1, 2023
The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR<sup>+</sup> CD8<sup>+</sup> effector state, and its deletion improves checkpoint blockadeSusan E McClory, Oishi Bardhan, Kelly S Rome, et al.
Molecular Cancer Therapeutics|August 14, 2013
EGFR inhibition promotes an aggressive invasion pattern mediated by mesenchymal-like tumor cells within squamous cell carcinomasDevraj Basu, Arnaud F Bewley, Steven M Sperry, et al.
Journal of Translational Medicine|December 17, 2009
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18Ioannis Alagkiozidis, Andrea Facciabene, Carmine Carpenito, et al.
Cancer Immunology, Immunotherapy : CII|October 25, 2011
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remissionChristina S Chu, Jean Boyer, Daniel S Schullery, et al.
Annals of Surgical Oncology|July 29, 2015
Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node PositivityEdmund K Bartlett, Madalyn G Peters, Anne Blair, et al.
Cancer Research|January 7, 2006
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinomaDavid A Tuveson, Liqin Zhu, Aarthi Gopinathan, et al.
Cancer Research|April 19, 2007
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage displayRolf K Swoboda, Rajasekharan Somasundaram, Laura Caputo, et al.
Pageof 15